Method Validation and Transfer with focus on the new ICH Q2(R2) MasterClass
12 September, 2022
This 1 day online masterclass gives practical examples from method validation and method transfer.
Online Masterclass gives practical examples from method validation and method transfer also Participants can ask questions interactively.
12 September, 2022, Virtual
Time Zone: UTC/GMT+1/CET
The new draft ICH guideline for method validation ICHQ2(R2) has been published for comment. Together with the new ICHQ14 guideline for method development, both guidelines represent a fundamental change of direction in method development and validation. This 1 day online training gives you practical examples from method validation and method transfer. Participants can ask questions interactively during the workshop.
#masterclass #glceurope #pharmaonlinetraining #globalleadingconferences #pharmamethodvalidation
Auregen BioTherapeutics GmbH
Who should attend?
• Quality control employees
• Specialists and managers from the areas of R&D, quality control and analytical chemistry
"High attention to detail in course content and very well delivered"
Product Development Manager
"Very good training led by two knowledgeable and open experts. Excellent insight given on many complex topics. Interactive and highly useful"
USP PD Team Manager
"Great course, impressed with the knowledge of the trainers and ability to answer wide variety of questions!"
Manager, Senior Investigator
MT Sword Laboratories (BMS)
Global Leadership Conferences began as an ambitious dream by three founders ten years ago. Today it’s an international series of interactive events, exploring the hottest topics in critical fields. Each year, thousands of professionals join us to challenge the status quo and learn innovative ways to create new solutions in Finance, Pharmaceutical, HR, Health & Safety, and Energy.know more >
Years of experience
Other events you may like
23 - 26 May, 2022
The focus of this two days pharma online masterclass will be on providing an update of ongoing activities regarding medicines’ risk and signal management.learn more >>